California Cancer Reporting System Standards, Volume III

IF1224: TNM T, Size, Uveal Melanoma (COC)

OWNER

CoC

EDIT SETS

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

FIELDS

TNM Clin T [NAACCR #940]

TNM Path T [NAACCR #880]

CS Site-Specific Factor 2 [NAACCR #2890]

CS Site-Specific Factor 3 [NAACCR #2900]

CS Site-Specific Factor 25 [NAACCR #2879]

Primary Site [NAACCR #400]

Date of Diagnosis [NAACCR #390]

Type of Reporting Source [NAACCR# 500]

Behavior Code ICD-O-3 [NAACCR# 523]

Histologic Type ICD-O-3  [NAACCR #522]

TABLE

TUMDEPTH.DBF

TUMDIMTR.DBF

MESSAGE

1. IF1224: If CS Site-Specific Factor 2 or CS Site-Specific Factor 3 is coded, the other SSF must not be blank

2. IF1224: TNM Clin T of [value] is not consistent with CS Site-Specific Factor 2 of [value]

3. IF1224: TNM Path T of [value] is not consistent with CS Site-Specific Factor 2 of [value]

4. IF1224: TNM Clin T of [value] and TNM Path T of [value] is not consistent with CS Site-Specific Factor 2 of [value] and CS Site-Specific Factor 3 of [value]

5. IF1224: TNM Clin T of [value] is not consistent with CS Site-Specific Factor 3 of [value]

6. IF1224: TNM Path T of [value] is not consistent with CS Site-Specific Factor 3 of [value]

specification

This edit checks for consistency between the TNM Clin T and TNM Path T categories and Tumor Size Category determined by the combination of Largest Basal Diameter and Thickness, coded in CS Site-Specific Factors 2 and 3 respectively.

This edit enforces the statement in the AJCC manual on page 12: “Carcinoma in situ (CIS) is an exception to the stage grouping guidelines. By definition, CIS has not involved any structure in the primary organ that would allow tumor cells to spread to regional nodes or distant sites. Therefore, pTis cN0 cM0 should be reported as both clinical and pathologic stage 0.” The statement on page 499 for bladder takes precedence for this site: “Pathologic staging is based on the histologic review of the radical or partial cystectomy specimen.”

This edit is skipped if any of the following conditions are true:

1. Year of Date of Diagnosis is less than 2016, blank (unknown), or invalid

2. Type of Reporting Source = 7 (Death Certificate Only)

3. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)

4. Site/Histology is not group 51A, uveal melanoma

5. TNM Path T and TNM Clin T are both blank or 88

6. Site Specific Factor 2 and Site Specific Factor 3 are both blank or 988

7. TNM Edition Number not = 07, U7

(Site/histology group is determined before skips 4 and 6 are applied.)

TNM Clin T and TNM Path T may be blank. If entered, they will be edited against tumor basal diameter and tumor depth coded in Site-Specific Factors 2 and 3 respectively. A pT category entered in TNM Path T will be compared to the tumor depth coded in a site-specific factor.

The edit will first compare the combination of basal diameter and depth to pT category entered in TNM Path T, and then to cT category entered in TNM Clin T. The edit comparisons will proceed as follows:

1. If TNM PATH T is empty:

1. TNM Clin T and Site-Specific Factor: Pass, edit passes

2. TNM Clin T and Site-Specific Factor: Fail, edit fails

2. If TNM Path T is coded:

1. TNM Path T and Site-Specific Factor: Pass, edit passes.

2. TNM Path T and Site-Specific Factor: Fail

1. If TNM Clin T is empty, edit fails

2. If TNM Clin T is coded:

1. TNM Clin T and Site-Specific Factor: Pass, edit passes

2. TNM Clin T and Site-Specific Factor: Fail, edit fails

An edit failure will be returned if the combination of diameter and depth is outside the range for the listed pT category, or if either diameter or depth is coded but the other is not. "980", "980 millimeters or larger", is the largest possible size. Nonspecific size values are converted to numeric values for purposes of the edit. For example, for basal diameter, the lowest value is converted to 001 (990>001), the highest value to the top of the range plus 1 (997>181), and the intervening values to the highest value in the range (993>090).

The TNM T categories corresponding to basal diameter and tumor depth are listed below, with the site-specific factor used to collect the information. The number next to each site title indicates the respective chapter in the AJCC Cancer Staging Manual, Edition 7.

The site/histology groups are identified by site and histology in the edit Primary Site, Stage Group 2016 - Ed 7.

51A. Ciliary Body and Choroid

SSF 2

SSF 3

historical changes